SEC 13F Intelligence

Cardinal Capital Management / BIIB

Cardinal Capital Management’s Biogen Inc Position

Does Cardinal Capital Management own Biogen Inc (BIIB)? Not currently — the last reported position was 30.5K shares worth $7M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q1 2024
Shares
30.5K
% of Portfolio
+1.07%
Quarters Held
22
position exited

Position History BIIB

Reported value by quarter
Q4 ’18: $5MQ4 ’18Q1 ’19: $4MQ2 ’19: $4MQ3 ’19: $4MQ3 ’19Q4 ’19: $5MQ1 ’20: $5MQ2 ’20: $4MQ2 ’20Q3 ’20: $5MQ4 ’20: $4MQ1 ’21: $5MQ1 ’21Q2 ’21: $6MQ3 ’21: $5MQ4 ’21: $4MQ4 ’21Q1 ’22: $6MQ2 ’22: $6MQ3 ’22: $6MQ3 ’22Q4 ’22: $8MQ1 ’23: $8MQ2 ’23: $8MQ2 ’23Q3 ’23: $7MQ4 ’23: $7MQ1 ’24: $7MQ1 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202430.5K$7M+1.07%
Q4 202327.6K$7M+1.35%
Q3 202327.6K$7M+1.45%
Q2 202327.3K$8M+1.56%
Q1 202327.1K$8M+1.56%
Q4 202227.2K$8M+1.61%
Q3 202224.2K$6M+1.53%
Q2 202227.3K$6M+1.28%
Q1 202227.2K$6M+1.16%
Q4 202117.1K$4M+0.81%
Q3 202117.5K$5M+1.07%
Q2 202117.6K$6M+1.28%
Q1 202117.4K$5M+1.07%
Q4 202017.0K$4M+0.98%
Q3 202016.7K$5M+1.31%
Q2 202016.7K$4M+1.29%
Q1 202016.8K$5M+1.75%
Q4 201916.7K$5M+1.29%
Q3 201917.0K$4M+1.09%
Q2 201917.0K$4M+1.13%
Q1 201917.2K$4M+1.16%
Q4 201817.2K$5M+1.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cardinal Capital Management’s full portfolio or all institutional holders of BIIB.